Evidence map›Paper›PMID 39886939›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2025

Comparative analysis of Caco-2 cells and human jejunal and duodenal enteroid-derived cells in gel- and membrane-based barrier models of intestinal permeability.

Haley L Moyer, Leoncio Vergara, Clifford Stephan, Courtney Sakolish, Lucie C Ford, Han-Hsuan D Tsai, Hsing-Chieh Lin, Weihsueh A Chiu, Remi Villenave, Philip Hewitt and 2 more

Abstract readComparative Study
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Haley L MoyerDepartment of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX 77843, United States.
Leoncio VergaraInstitute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, United States.
Clifford StephanInstitute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, United States.
Courtney SakolishDepartment of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX 77843, United States.
Lucie C FordDepartment of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX 77843, United States.
Han-Hsuan D TsaiDepartment of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX 77843, United States.ORCID 0000-0002-3484-5955
Hsing-Chieh LinDepartment of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX 77843, United States.ORCID 0000-0002-7576-5943
Weihsueh A ChiuDepartment of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX 77843, United States.ORCID 0000-0002-7575-2368
Remi VillenaveRoche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel 4070, Switzerland.
Philip HewittMerck KGaA, Darmstadt 64293, Germany.ORCID 0000-0002-2741-3409
Stephen S FergusonDivision of Translational Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, United States.ORCID 0000-0003-3172-8347
Ivan RusynDepartment of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX 77843, United States.

Funding

Single cell, multi-parametric high throughput platform to classify endocrine disruptor potential of mixturesP42ES027704 · NIEHS · TEXAS A&M UNIVERSITY · PI Efstratios Pistikopoulos · 2017 to 2026
$21.2M
Regulatory Science in Environmental Health and ToxicologyT32ES026568 · NIEHS · TEXAS A&M UNIVERSITY · PI Weihsueh A Chiu, Natalie M Johnson · 2016 to 2026
$3.8M
IMSD at Texas A&M University: Initiative for Maximizing Student Diversity in Biomedical SciencesT32GM135748 · NIGMS · TEXAS A&M UNIVERSITY · PI BRINKMEYER-LANGFORD, CANDICE L., CHIU, WEIHSUEH A · 2020 to 2024
$1.2M
American Chemistry CouncilBristol-Myers SquibbMerck Healthcare KGaANIEHS NIH HHSNIEHS NIH HHS P42 ES027704NIEHS NIH HHS T32 ES026568NIGMS NIH HHS T32 GM135748NIH HHS P42 ES027704SanofiUnited States Environmental Protection Agency
6 · The paper itself

Abstract

Intestinal absorption is a key toxicokinetics parameter. Although the colon carcinoma cell line Caco-2 is the most used in vitro model to estimate human drug absorption, models representing other intestinal segments are available. We characterized the morphology, tissue-specific markers, and functionality of 3 human intestinal cell types: Caco-2, primary human enteroid-derived cells from jejunum (J2), and duodenum (D109) when cultured in the OrganoPlate 3-lane 40 microphysiological system (MPS) or static 24-well Transwells. In both conditions, J2 and D109 formed dome-like structures; Caco-2 formed uniform monolayers. In MPS, only Caco-2 formed tubules. Cells grown on Transwells formed a thicker monolayer. All cells and conditions exhibited expression of ZO-1 (tight junctions). Polarization markers Ezrin and Villin were highest in J2 and D109 in MPS, highest expression of Mucin was observed with J2. However, J2 and D109 exhibited poor barrier (70 kDa TRITC-dextran) in MPS, whereas robust barrier was recorded in Transwells. Barrier function and drug transport were evaluated using caffeine, indomethacin, and propranolol. The gel lane in MPS acted as a blockade; only a small fraction crossed, even without cells. The permeability ratios were used to parameterize the probabilistic compartmental absorption model to determine whether in vitro data could reduce uncertainty. The most accurate prediction of the fraction absorbed was achieved with Transwell-derived data from Caco-2, combined with the experimentally derived segment-specific absorption ratios. The impact of this study includes demonstration that enteroid-derived cells cultured in MPS show most physiological morphology, but that studies of drug permeability in this MPS are challenging.

Indexed as

DuodenumIntestinal AbsorptionIntestinal MucosaJejunumOrganoidsCaco-2 CellsGelsHumansIntestinal Barrier FunctionModels, BiologicalPermeabilityGelsgutpermeabilitytissue chip

Identifiers

PMID39886939
PMCPMC11939079

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.